Sectoral Asset Management Inc Vir Biotechnology, Inc. Transaction History

Sectoral Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $80,136 - $112,140	4,200 New	4,200 $107,000
Q1 2022 May 10, 2022	SELL	$21.19 - $40.01 $127,140 - $240,060	-6,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$30.97 - $54.03 $185,820 - $324,180	6,000 New	6,000 $251,000
Q3 2020 Nov 13, 2020	SELL	$28.28 - $53.6 $200,788 - $380,560	-7,100 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$27.89 - $47.86 $198,019 - $339,806	7,100 New	7,100 $291,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.